These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 11845283)

  • 41. Mouse models of Prader-Willi Syndrome: a systematic review.
    Bervini S; Herzog H
    Front Neuroendocrinol; 2013 Apr; 34(2):107-19. PubMed ID: 23391702
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unique maternal deletion of 15q in a patient with some symptoms of Prader-Willi syndrome.
    Ninomiya S; Yokoyama Y; Kawakami M; Une T; Maruyama H; Morishima T
    Pediatr Int; 2005 Oct; 47(5):541-5. PubMed ID: 16190961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Comprehensive Review of Genetically Engineered Mouse Models for Prader-Willi Syndrome Research.
    Kummerfeld DM; Raabe CA; Brosius J; Mo D; Skryabin BV; Rozhdestvensky TS
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807162
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Establishing the epigenetic status of the Prader-Willi/Angelman imprinting center in the gametes and embryo.
    Kantor B; Kaufman Y; Makedonski K; Razin A; Shemer R
    Hum Mol Genet; 2004 Nov; 13(22):2767-79. PubMed ID: 15367489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The imprinting mechanism of the Prader-Willi/Angelman regional control center.
    Perk J; Makedonski K; Lande L; Cedar H; Razin A; Shemer R
    EMBO J; 2002 Nov; 21(21):5807-14. PubMed ID: 12411498
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Towards a molecular understanding of Prader-Willi and Angelman syndromes.
    Mann MR; Bartolomei MS
    Hum Mol Genet; 1999; 8(10):1867-73. PubMed ID: 10469839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Parent-specific complementary patterns of histone H3 lysine 9 and H3 lysine 4 methylation at the Prader-Willi syndrome imprinting center.
    Xin Z; Allis CD; Wagstaff J
    Am J Hum Genet; 2001 Dec; 69(6):1389-94. PubMed ID: 11592036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation of induced pluripotent stem cells (KSCBi009-A) from a patient with Prader-Willi syndrome (PWS) featuring deletion of the paternal chromosome region 15q11.2-q13.
    Kim BY; Lee JS; Kim YO; Koo SK; Park MH
    Stem Cell Res; 2020 Jul; 46():101847. PubMed ID: 32474395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prader-Willi syndrome and genomic imprinting].
    Wang W; Wang DF; Cui YF; Ni JH; Dong ZY; Fu MF; Fu HM; Lu GQ; Chen FS
    Zhonghua Er Ke Za Zhi; 2003 Jun; 41(6):453-6. PubMed ID: 14749005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exclusion of SNRPN as a major determinant of Prader-Willi syndrome by a translocation breakpoint.
    Schulze A; Hansen C; Skakkebaek NE; Brøndum-Nielsen K; Ledbeter DH; Tommerup N
    Nat Genet; 1996 Apr; 12(4):452-4. PubMed ID: 8630505
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Paternal deletion from Snrpn to Ube3a in the mouse causes hypotonia, growth retardation and partial lethality and provides evidence for a gene contributing to Prader-Willi syndrome.
    Tsai TF; Jiang YH; Bressler J; Armstrong D; Beaudet AL
    Hum Mol Genet; 1999 Aug; 8(8):1357-64. PubMed ID: 10400982
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Small nuclear ribonucleoprotein polypeptide N (SNRPN), an expressed gene in the Prader-Willi syndrome critical region.
    Ozçelik T; Leff S; Robinson W; Donlon T; Lalande M; Sanjines E; Schinzel A; Francke U
    Nat Genet; 1992 Dec; 2(4):265-9. PubMed ID: 1303277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mosaicism for maternal uniparental disomy 15 in a boy with some clinical features of Prader-Willi syndrome.
    Zilina O; Kahre T; Talvik I; Oiglane-Shlik E; Tillmann V; Ounap K
    Eur J Med Genet; 2014; 57(6):279-83. PubMed ID: 24704109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Whole genome microarray analysis of gene expression in an imprinting center deletion mouse model of Prader-Willi syndrome.
    Bittel DC; Kibiryeva N; McNulty SG; Driscoll DJ; Butler MG; White RA
    Am J Med Genet A; 2007 Mar; 143A(5):422-9. PubMed ID: 17036336
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imprinting-mutation mechanisms in Prader-Willi syndrome.
    Ohta T; Gray TA; Rogan PK; Buiting K; Gabriel JM; Saitoh S; Muralidhar B; Bilienska B; Krajewska-Walasek M; Driscoll DJ; Horsthemke B; Butler MG; Nicholls RD
    Am J Hum Genet; 1999 Feb; 64(2):397-413. PubMed ID: 9973278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. De novo deletions of SNRPN exon 1 in early human and mouse embryos result in a paternal to maternal imprint switch.
    Bielinska B; Blaydes SM; Buiting K; Yang T; Krajewska-Walasek M; Horsthemke B; Brannan CI
    Nat Genet; 2000 May; 25(1):74-8. PubMed ID: 10802660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disruption of the mouse necdin gene results in early post-natal lethality.
    Gérard M; Hernandez L; Wevrick R; Stewart CL
    Nat Genet; 1999 Oct; 23(2):199-202. PubMed ID: 10508517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader-Willi syndrome.
    Kim Y; Lee HM; Xiong Y; Sciaky N; Hulbert SW; Cao X; Everitt JI; Jin J; Roth BL; Jiang YH
    Nat Med; 2017 Feb; 23(2):213-222. PubMed ID: 28024084
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exclusion of the C/D box snoRNA gene cluster HBII-52 from a major role in Prader-Willi syndrome.
    Runte M; Varon R; Horn D; Horsthemke B; Buiting K
    Hum Genet; 2005 Feb; 116(3):228-30. PubMed ID: 15565282
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prader-Willi syndrome and Angelman syndrome.
    Buiting K
    Am J Med Genet C Semin Med Genet; 2010 Aug; 154C(3):365-76. PubMed ID: 20803659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.